OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artesunate exerts an anti‐immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression
Lixin Zhang, Zhineng Liu, Jun Ye, et al.
Cell Biology International (2014) Vol. 38, Iss. 5, pp. 639-646
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang, Jin Xu, Bo Zhang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 968

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 453

Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Yin Kwan Wong, Chengchao Xu, Karunakaran Kalesh, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1492-1517
Closed Access | Times Cited: 215

Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang, Chengchao Xu, Yin Kwan Wong, et al.
Engineering (2018) Vol. 5, Iss. 1, pp. 32-39
Open Access | Times Cited: 157

A comprehensive overview of Artemisinin and its derivatives as anticancer agents
Zi-wei Zeng, Di Chen, Lei Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115000-115000
Closed Access | Times Cited: 45

Antitumor Research on Artemisinin and Its Bioactive Derivatives
Yunqin Zhang, Guowei Xu, Shuqun Zhang, et al.
Natural Products and Bioprospecting (2018) Vol. 8, Iss. 4, pp. 303-319
Open Access | Times Cited: 83

Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate‑induced apoptosis
Feng Jiang, Jin‐Yong Zhou, Dan Zhang, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 81

Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives
Archana Bhaw‐Luximon, Dhanjay Jhurry
Cancer Chemotherapy and Pharmacology (2017) Vol. 79, Iss. 3, pp. 451-466
Closed Access | Times Cited: 72

Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
Cangcang Xu, Huihui Zhang, Lingli Mu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 63

Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 31

Phytomedicine polypharmacology: Cancer therapy through modulating the tumor microenvironment and oxylipin dynamics
Maria Karmella Apaya, Meng‐Ting Chang, Lie‐Fen Shyur
Pharmacology & Therapeutics (2016) Vol. 162, pp. 58-68
Closed Access | Times Cited: 52

The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review
Yifei Dai, Zhou Wei-wei, Jing Meng, et al.
Medicinal Chemistry Research (2017) Vol. 26, Iss. 5, pp. 867-880
Closed Access | Times Cited: 51

Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment
Zhe Ren, Kaiqing Yang, Lin Zhu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111934-111934
Closed Access | Times Cited: 5

Artesunate Induces Apoptosis of Bladder Cancer Cells by miR-16 Regulation of COX-2 Expression
Wei Zuo, Zhenzhong Wang, Jun Xue
International Journal of Molecular Sciences (2014) Vol. 15, Iss. 8, pp. 14298-14312
Open Access | Times Cited: 50

Immunomodulation of artemisinin and its derivatives
Wenbo Yao, Feng Wang, Hui Wang
Science Bulletin (2016) Vol. 61, Iss. 18, pp. 1399-1406
Closed Access | Times Cited: 44

Artesunate promotes Th1 differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142
Xiao Chen, Xueling Zhang, Guohua Zhang, et al.
Brazilian Journal of Medical and Biological Research (2019) Vol. 52, Iss. 5
Open Access | Times Cited: 39

Prevention of carcinogenesis and metastasis by Artemisinin-type drugs
Mohammed Abba, Nitin Patil, Jörg H. Leupold, et al.
Cancer Letters (2018) Vol. 429, pp. 11-18
Closed Access | Times Cited: 38

Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL‐4—producing T cells and regulatory T cells
Zhixia Li, Xiajie Shi, Junbin Liu, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8241-8248
Open Access | Times Cited: 36

Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target
Yanhui Zhou, Yanhui Cui, Ting Wang, et al.
Advances in clinical chemistry (2020), pp. 117-140
Closed Access | Times Cited: 35

Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells
Robert Hoffman, Changyu Li, Kai He, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 33

The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future
Hung‐Yu Lin, Hui‐Wen Ho, Yen‐Hsiang Chang, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 27

Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy
Qi Shang, Wandong Liu, Faith Leslie, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1525-1541
Open Access | Times Cited: 11

The Role of Traditional Chinese Medicine in the Management of Cervical Cancer
Dailin Wu, Rui-Sheng Zhou, H. S. Chen, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 04, pp. 1013-1025
Closed Access | Times Cited: 4

Natural medicines target tumor vascular microenvironment to inhibit tumor
Yirui Lu, Zhiliang Guo, Hong Li, et al.
Genes & Diseases (2025), pp. 101623-101623
Open Access

Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression
Lixin Zhang, Hua Qian, Min Sha, et al.
PLoS ONE (2016) Vol. 11, Iss. 10, pp. e0164838-e0164838
Open Access | Times Cited: 37

Page 1 - Next Page

Scroll to top